Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

10
(from Reference Citation Analysis)

Article PDFs (3)

Cited by > 0 (10)

Searched Name

Ramachandran Rakesh

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Huang F, Nguyen TT, Echeverria I, Rakesh R, Cary DC, Paculova H, Sali A, Weiss A, Peterlin BM, Fujinaga K. Reversible phosphorylation of cyclin T1 promotes assembly and stability of P-TEFb. eLife 2021;10:68473. [PMID: 34821217 PMCID: PMC8648303 DOI: 10.7554/elife.68473] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 11/19/2021] [Indexed: 01/06/2023] Open

Affiliation(s)

Fang Huang Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States
Trang Tt Nguyen Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States.,The Howard Hughes Medical Institute, San Francisco, United States
Ignacia Echeverria Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.,Departmentof Cellular Molecular Pharmacology, California Institute for Quantitative Biosciences (QBI), and Department of Bioengineering and Therapeutic Sciences, San Francisco, United States
Ramachandran Rakesh Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.,Departmentof Cellular Molecular Pharmacology, California Institute for Quantitative Biosciences (QBI), and Department of Bioengineering and Therapeutic Sciences, San Francisco, United States
Daniele C Cary Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States
Hana Paculova Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
Andrej Sali Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.,Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences (QBI), San Francisco, United States
Arthur Weiss Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States.,The Howard Hughes Medical Institute, San Francisco, United States
Boris Matija Peterlin Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States
Koh Fujinaga Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.,Department of Medicine, San Francisco, United States

Collapse

Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020;583:459-468. [PMID: 32353859 PMCID: PMC7431030 DOI: 10.1038/s41586-020-2286-9] [Citation(s) in RCA: 2844] [Impact Index Per Article: 711.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 04/22/2020] [Indexed: 02/07/2023]

Affiliation(s)

David E Gordon QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Gwendolyn M Jang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Mehdi Bouhaddou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jiewei Xu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kirsten Obernier QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kris M White Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Matthew J O'Meara Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Veronica V Rezelj Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Jeffrey Z Guo QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Danielle L Swaney QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Tia A Tummino QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Ruth Hüttenhain QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Robyn M Kaake QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Alicia L Richards QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Beril Tutuncuoglu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Helene Foussard QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jyoti Batra QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kelsey Haas QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Maya Modak QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Minkyu Kim QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Paige Haas QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Benjamin J Polacco QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Hannes Braberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jacqueline M Fabius QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Manon Eckhardt QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Margaret Soucheray QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Melanie J Bennett QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Merve Cakir QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Michael J McGregor QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Qiongyu Li QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Bjoern Meyer Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Ferdinand Roesch Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Thomas Vallet Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Alice Mac Kain Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Lisa Miorin Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Elena Moreno Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Zun Zar Chi Naing QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Yuan Zhou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Shiming Peng QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Ying Shi QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Ziyang Zhang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Wenqi Shen QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Ilsa T Kirby QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
James E Melnyk QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
John S Chorba QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Kevin Lou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Shizhong A Dai QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Inigo Barrio-Hernandez European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Danish Memon European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Claudia Hernandez-Armenta European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Jiankun Lyu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Christopher J P Mathy QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Tina Perica QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Kala Bharath Pilla QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Sai J Ganesan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Daniel J Saltzberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Ramachandran Rakesh QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Xi Liu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Sara B Rosenthal Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego, San Diego, CA, USA
Lorenzo Calviello QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Srivats Venkataramanan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Jose Liboy-Lugo QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Yizhu Lin QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Xi-Ping Huang Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
YongFeng Liu Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
Stephanie A Wankowicz QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, USA
Markus Bohn QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Maliheh Safari QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Fatima S Ugur QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Cassandra Koh Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Nastaran Sadat Savar Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Quang Dinh Tran Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Djoshkun Shengjuler Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Sabrina J Fletcher Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Michael C O'Neal Zoic Labs, Culver City, CA, USA
Yiming Cai Zoic Labs, Culver City, CA, USA
Jason C J Chang Zoic Labs, Culver City, CA, USA
David J Broadhurst Zoic Labs, Culver City, CA, USA
Saker Klippsten Zoic Labs, Culver City, CA, USA
Phillip P Sharp Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Nicole A Wenzell QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Duygu Kuzuoglu-Ozturk QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA Department of Urology, University of California San Francisco, San Francisco, CA, USA
Hao-Yuan Wang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Raphael Trenker QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
Janet M Young Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Devin A Cavero QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Joseph Hiatt QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA
Theodore L Roth QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA
Ujjwal Rathore QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Advait Subramanian QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Julia Noack QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Mathieu Hubert Virus and Immunity Unit, Institut Pasteur, Paris, France
Robert M Stroud QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Alan D Frankel QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Oren S Rosenberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Kliment A Verba QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
David A Agard QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Melanie Ott QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA J. David Gladstone Institutes, San Francisco, CA, USA Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Michael Emerman Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Natalia Jura QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
Mark von Zastrow QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA
Eric Verdin QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Medicine, University of California San Francisco, San Francisco, CA, USA Buck Institute for Research on Aging, Novato, CA, USA
Alan Ashworth QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
Olivier Schwartz Virus and Immunity Unit, Institut Pasteur, Paris, France
Christophe d'Enfert Direction Scientifique, Institut Pasteur, Paris, France
Shaeri Mukherjee QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Matt Jacobson QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Harmit S Malik Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Danica G Fujimori QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Trey Ideker QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Division of Genetics, Department of Medicine, University of California San Diego, San Diego, CA, USA
Charles S Craik QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
Stephen N Floor QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
James S Fraser QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
John D Gross QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Andrej Sali QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Bryan L Roth Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
Davide Ruggero QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA Department of Urology, University of California San Francisco, San Francisco, CA, USA
Jack Taunton QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Tanja Kortemme QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Pedro Beltrao QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Marco Vignuzzi Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.
Adolfo García-Sastre Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kevan M Shokat QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.
Brian K Shoichet QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Nevan J Krogan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. J. David Gladstone Institutes, San Francisco, CA, USA. Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Collapse

Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020. [PMID: 32353859 DOI: 10.1038/s41586‐020‐2286‐9] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]

Affiliation(s)

David E Gordon QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Gwendolyn M Jang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Mehdi Bouhaddou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jiewei Xu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kirsten Obernier QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kris M White Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.,Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Matthew J O'Meara Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Veronica V Rezelj Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Jeffrey Z Guo QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Danielle L Swaney QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Tia A Tummino QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Ruth Hüttenhain QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Robyn M Kaake QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Alicia L Richards QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Beril Tutuncuoglu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Helene Foussard QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jyoti Batra QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Kelsey Haas QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Maya Modak QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Minkyu Kim QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Paige Haas QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Benjamin J Polacco QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Hannes Braberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Jacqueline M Fabius QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Manon Eckhardt QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Margaret Soucheray QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Melanie J Bennett QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Merve Cakir QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Michael J McGregor QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Qiongyu Li QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Bjoern Meyer Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Ferdinand Roesch Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Thomas Vallet Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Alice Mac Kain Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Lisa Miorin Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.,Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Elena Moreno Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.,Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Zun Zar Chi Naing QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Yuan Zhou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Shiming Peng QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Ying Shi QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Ziyang Zhang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Wenqi Shen QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Ilsa T Kirby QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
James E Melnyk QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
John S Chorba QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Kevin Lou QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Shizhong A Dai QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA
Inigo Barrio-Hernandez European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Danish Memon European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Claudia Hernandez-Armenta European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Jiankun Lyu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Christopher J P Mathy QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.,The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Tina Perica QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Kala Bharath Pilla QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Sai J Ganesan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Daniel J Saltzberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Ramachandran Rakesh QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Xi Liu QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Sara B Rosenthal Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego, San Diego, CA, USA
Lorenzo Calviello QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Srivats Venkataramanan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Jose Liboy-Lugo QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Yizhu Lin QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA
Xi-Ping Huang Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
YongFeng Liu Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
Stephanie A Wankowicz QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.,Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, USA
Markus Bohn QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Maliheh Safari QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Fatima S Ugur QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Cassandra Koh Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Nastaran Sadat Savar Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Quang Dinh Tran Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Djoshkun Shengjuler Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Sabrina J Fletcher Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France
Michael C O'Neal Zoic Labs, Culver City, CA, USA
Yiming Cai Zoic Labs, Culver City, CA, USA
Jason C J Chang Zoic Labs, Culver City, CA, USA
David J Broadhurst Zoic Labs, Culver City, CA, USA
Saker Klippsten Zoic Labs, Culver City, CA, USA
Phillip P Sharp Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Nicole A Wenzell QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Duygu Kuzuoglu-Ozturk QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.,Department of Urology, University of California San Francisco, San Francisco, CA, USA
Hao-Yuan Wang QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Raphael Trenker QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
Janet M Young Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Devin A Cavero QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Joseph Hiatt QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA
Theodore L Roth QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.,Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA
Ujjwal Rathore QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Advait Subramanian QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Julia Noack QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Mathieu Hubert Virus and Immunity Unit, Institut Pasteur, Paris, France
Robert M Stroud QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Alan D Frankel QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Oren S Rosenberg QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.,Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Kliment A Verba QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
David A Agard QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
Melanie Ott QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,J. David Gladstone Institutes, San Francisco, CA, USA.,Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Michael Emerman Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Natalia Jura QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
Mark von Zastrow QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA
Eric Verdin QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Medicine, University of California San Francisco, San Francisco, CA, USA.,Buck Institute for Research on Aging, Novato, CA, USA
Alan Ashworth QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
Olivier Schwartz Virus and Immunity Unit, Institut Pasteur, Paris, France
Christophe d'Enfert Direction Scientifique, Institut Pasteur, Paris, France
Shaeri Mukherjee QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA
Matt Jacobson QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Harmit S Malik Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Danica G Fujimori QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Trey Ideker QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Division of Genetics, Department of Medicine, University of California San Diego, San Diego, CA, USA
Charles S Craik QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.,Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
Stephen N Floor QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.,Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
James S Fraser QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
John D Gross QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
Andrej Sali QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Bryan L Roth Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
Davide Ruggero QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.,Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.,Department of Urology, University of California San Francisco, San Francisco, CA, USA
Jack Taunton QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA
Tanja Kortemme QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.,Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.,The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Pedro Beltrao QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.,European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
Marco Vignuzzi Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.
Adolfo García-Sastre Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .,Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .,Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .,The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kevan M Shokat QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. .,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. .,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. .,Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.
Brian K Shoichet QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. .,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. .,Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Nevan J Krogan QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. .,Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. .,J. David Gladstone Institutes, San Francisco, CA, USA. .,Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. .,Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Collapse

Rakesh R, Krishnan R, Sattlegger E, Srinivasan N. Recognition of a structural domain (RWDBD) in Gcn1 proteins that interacts with the RWD domain containing proteins. Biol Direct 2017;12:12. [PMID: 28526057 PMCID: PMC5438488 DOI: 10.1186/s13062-017-0184-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Accepted: 05/12/2017] [Indexed: 11/12/2022] Open

Sinha VP, Kohli D, Rakesh R, Thakar PV, Kumar A. Study on Chemical Interaction of U3Si2Dispersoid and Aluminum Matrix in Plate Fuel Elements and Its Influence on the Mechanical Properties. NUCL TECHNOL 2017. [DOI: 10.13182/nt14-59] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Rakesh R, Joseph AP, Bhaskara RM, Srinivasan N. Structural and mechanistic insights into human splicing factor SF3b complex derived using an integrated approach guided by the cryo-EM density maps. RNA Biol 2016;13:1025-1040. [PMID: 27618338 DOI: 10.1080/15476286.2016.1218590] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open

Rakesh R, Srinivasan N. Improving the Accuracy of Fitted Atomic Models in Cryo-EM Density Maps of Protein Assemblies Using Evolutionary Information from Aligned Homologous Proteins. Methods Mol Biol 2016;1415:193-209. [PMID: 27115634 DOI: 10.1007/978-1-4939-3572-7_10] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]

Sonak S, Rakesh R, Jain U, Mukherjee A, Kumar S, Krishnamurthy N. Thermogravimetric study of the kinetics of lithium titanate reduction by hydrogen. Fusion Engineering and Design 2014. [DOI: 10.1016/j.fusengdes.2014.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]

Pingali S, Vijayakumar M, Rao PSM, Rakesh R, Mukherjee G. Renal angiomyolipoma - sarcomatous transformation and cavoatrial extension. Indian J Surg Oncol 2014;4:27-9. [PMID: 24426695 DOI: 10.1007/s13193-012-0188-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2011] [Accepted: 10/02/2012] [Indexed: 10/27/2022] Open

Rakesh R, Anoop KR. Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium. J Pharm Bioallied Sci 2012;4:333-40. [PMID: 23248569 PMCID: PMC3523531 DOI: 10.4103/0975-7406.103274] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2012] [Revised: 03/21/2012] [Accepted: 05/18/2012] [Indexed: 11/22/2022] Open